DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
4.445
+0.205 (4.83%)
May 29, 2026, 11:23 AM EDT - Market open

DNA X Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7416331717
Market Cap Growth
-36.94%-74.70%-51.60%87.76%-0.07%-63.88%
Enterprise Value
6.48.9710.4123.144.126.17
Last Close Price
4.453.1556.88132.3076.50165.96
PS Ratio
---0.350.250.32
PB Ratio
--0.50-2.761.450.860.93
P/TBV Ratio
-4.32-0.29-2.621.410.610.05
EV/Sales Ratio
---0.250.060.11
EV/EBITDA Ratio
--22.778.51--
EV/EBIT Ratio
---45.11--
Debt / Equity Ratio
-12.92-0.750000.00
Debt / EBITDA Ratio
0.33-----
Net Debt / Equity Ratio
0.13-0.470.94-0.42-0.65-0.59
Net Debt / EBITDA Ratio
-0.04-3.40-11.69-3.461.090.31
Net Debt / FCF Ratio
0.01-0.160.612.301.050.29
Asset Turnover
-001.711.471.19
Inventory Turnover
--014.2512.315.70
Quick Ratio
1.170.030.121.111.181.16
Current Ratio
1.440.600.741.361.361.70
Return on Equity (ROE)
115.36%128.03%-34.59%-0.42%-72.85%-164.23%
Return on Assets (ROA)
--12.93%-6.47%-0.30%-30.55%-83.51%
Return on Invested Capital (ROIC)
--15.17%-12.94%-1.40%-163.74%-451.40%
Return on Capital Employed (ROCE)
-132.99%-31.16%2.25%-68.49%-152.18%
Buyback Yield / Dilution
-240.16%-175.71%-10.04%-48.42%-2952.34%-104.82%
Total Shareholder Return
-240.16%-175.71%-10.04%-48.42%-2952.34%-104.82%
Updated May 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q